CERALYTE 50 OTC
Generic Name and Formulations:
Rice syrup solids 40g, sodium 50mEq, potassium 20mEq, chloride 40mEq, citrate 30mEq, Calories 160; per liter; pwd (mixed berry flavor) or ready-to-drink (lemon flavor).
Cera Products Inc.
Indications for CERALYTE 50:
Oral fluid and electrolyte replacement in mild (CeraLyte 50) to moderate (CeraLyte 70, CeraLyte 90) diarrhea.
Adults and Children:
Take with food. Mix powder as directed per packet. Drink sufficient volume to replace fluid lost. Continue until diarrhea stops.
As sole therapy in severe diarrhea. Intractable vomiting. Adynamic ileus. Intestinal obstruction. Perforated bowel. Anuria. Oliguria. Impaired homeostatic mechanisms.
Avoid sugary food/fruit drinks, colas.
Fluid & electrolyte replacement.
Pwd packets: 10g (for 200mL)—24; 50g (for 1L)—12; Ready-to-Drink (11oz)—4
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|